Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial

J A Cohen1, G R Cutter, J S Fischer

  • 1The Mellen Center-U10, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA. cohenj@ccf.org

Archives of Neurology
|June 19, 2001
PubMed
Abstract